Biochemical Predictors of Delirium in Cardiac Surgery
Biochemical Predictors of Delirium in Patients Undergoing Cardiac Surgery Under Cardiopulmonary Bypass
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Vladimir Lomivorotov, MD, PhD
- Phone Number: 83833476058
- Email: v.lomivorotov@gmail.com
Study Contact Backup
- Name: Gleb Moroz
- Email: glebmorozz@gmail.com
Study Locations
-
-
-
Novosibirsk, Russian Federation, 630055
- Recruiting
- E. Meshalkin National Medical Research Center
-
Contact:
- Vladimir Lomivorotov
- Phone Number: 89139164103
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- surgery under cardiopulmonary bypass
- Age > 60 years
- CABG surgery or valve surgery (repair/replacement)
Exclusion Criteria:
- urgent surgery
- surgery on aorta
- combined procedures (CABG+valves)
- significant stenosis of carotid arteries
- Parkinson's disease
- liver cirrhosis
- use of anticholinergic drugs, antidepressants, antiepileptic or chemotherapy drugs
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Study cohort
Patients undergoing surgery under cardiopulmonary bypass
|
Blood will be collected in all patients blood before surgery and after surgery (postoperative day 1).
Our study is based on a polar metabolomics profiling of plasma and/or serum using hybrid triple quadrupole mass spectrometer coupled with chromatographic system.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postoperative delirium
Time Frame: 5 days after surgery
|
Postoperative delirium will be diagnosed with CAM-ICU (confusion assessment method - intensive care unit)
|
5 days after surgery
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (ACTUAL)
Study Start
Primary Completion (ANTICIPATED)
Primary Completion
Study Completion (ANTICIPATED)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ACTUAL)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- DEL2019
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.